Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox

Phase 4

Suspended

• Conditions: Healthy
• Interventions: Dietary Supplement: Mineralox C

• Registration Number: NCT00623675
• Lead Sponsor: CreoMed, Inc.

Brief Summary

Researchers want to find out if urine heavy metal levels are changed in persons who use Mineralox Basic C™ (Mineralox). Mineralox is a zeolite (clinoptilolite) in combination with Vitamin C. Zeolites are natural supplements (nutraceuticals) that work at the cellular level to remove heavy metals and toxins that are accumulated in every day life safely from the body through the urine. The study doctor will give Mineralox to 20 people in this study to see if it helps with the heavy metal removal from the body.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Study First Submitted: 2008-02-17
• Study First Submitted QC: 2008-02-25
• Study First Posted: 2008-02-26
• Status Verified: 2009-07
• Last Update Submitted: 2009-07-06
• Last Update Posted: 2009-07-07

Recruitment & Eligibility

• Status: SUSPENDED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Females and Males age 18-75 without significant health problems as determined by the Principal Investigator.
2. Nonsmoker
3. Ability to understand informed consent

Exclusion Criteria

1. Pregnancy
2. Any serious or unstable disease within 6 months; seizure risk; diabetes mellitus requiring insulin or oral hypoglycemic medication; diagnosis of eating disorder, use of MAOI in the prior 14 days; hepatic or renal impairment; clinically significant cardiovascular disease within 6 months; uncontrolled hypertension; severe chronic obstructive pulmonary disease; baseline systolic blood pressure higher than150mm Hg or diastolic blood pressure higher than 95 mm Hg; history of cancer (except treated basal cell or squamous cell carcinoma of the skin); history of clinically significant allergic reactions or laboratory abnormalities,and patients taking AREDS Eye Vitamins.
3. Major depressive disorder within the past year requiring treatment; history of panic disorder, psychosis, bipolar disorder, or eating disorder
4. Intention to donate blood or blood products during treatment phase of the study;
5. Alcohol or drug abuse/dependency within the past year
6. Use of tobacco products other than cigarettes or use of marijuana
7. Body mass index (calculated as weight in kilograms divided by the square height in meters) less than 15 or greater than 38 or weight less than 45.5 kg
8. NRT, antidepressants, antipsychotics, mood stabilizers/anticonvulsants, naltrexone, steroids or insulin.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
A	Mineralox C	-

Primary Outcome Measures

Name	Time	Method
Heavy Metal Urine Analysis	3 months

Trial Locations

Locations (1)

NEMA Research; 🇺🇸 Naples, Florida, United States